Doxazosin
- Product NDC
- 68071-3811
- 11-digit product format
- 680713811
- Labeler code
- 68071
- Product ID
- 68071-3811_30b6f043-d418-812c-e063-6294a90ad442
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA208719
- Marketing category
- ANDA
- Marketing start
- 2017-08-31
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197626 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3811-6 | Doxazosin | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-3811 | DOXAZOSIN TABLET [NUCARE PHARMACEUTICALS, INC.] | 1 | Current NDC, 1 package rows | 20250322_30b709d6-c438-c721-e063-6294a90abd61.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68071-3811-6 | 68071381106 | 60 TABLET in 1 BOTTLE (68071-3811-6) | 60 tablet | 2025-03-19 | No | No | Historical |